Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results
This article is from
The Cancer Letter
archive.
Vol. 13 No. 23 | June 5, 1987
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Committee Unblinds Phase III Zytiga Study
March 30, 2012
TCL Archive
FDA, HCFA Form Council On Biomedical Imaging.
November 10, 2000
TCL Archive
Biostatistician Thomas Fleming Warns Against Approval of Provenge.
May 4, 2007
TCL Archive
Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months
April 25, 2014
TCL Archive
AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds
January 17, 1992
TCL Archive
Kirsten Goldberg Leaves The Cancer Letter For ASCO
January 7, 2011